Skip to content
ImmuPharma PLC
  • Science
    • Our Science
    • Autoimmunity
      • P140
      • Type M & Diagnostic
    • Type 1 Diabetes
      • Kapiglucagon
    • Anti-infectives
      • BioAMB
      • BioCIN
    • Pipeline
  • Company
    • Mission
    • About Us
    • Our Team
    • ImmuPharma Biotech
  • Investors
    • Investors
    • AIM Rule 26 Information
    • Regulatory News
    • Corporate Governance
    • Board of Directors
    • Annual Reports
    • Advisers
    • Email Alert
  • Updates
    • Announcements
    • Interviews
    • In the Media
  • Contact

OUR MISSION

Curing Autoimmune Diseases

At ImmuPharma, we believe a future free from autoimmune diseases is possible.

Our mission is simple yet bold: to pave the way to a cure, where most existing approaches focus only on relieving symptoms.

Today, the vast majority of autoimmune treatments aim to control pain and inflammation without addressing the underlying causes of disease. We refuse to accept this as inevitable.

Our vision is built on a strong conviction:

By understanding, restoring, and rebalancing the immune system, true remission — even cure — can be achieved.

Through cutting-edge science, a deep mechanistic understanding, and strategic partnerships, we are developing therapies designed to correct immune dysregulation at its source, not just mask it.

Our mission is to bring patients:

  • Innovative therapies that restore immune tolerance,
  • Sustainable health benefits that go beyond symptom management,
  • New hope for millions of people worldwide.

At ImmuPharma, we don’t just imagine a different future for autoimmune diseases.
We’re building it.

Learn more
  • AIM Rule 26
  • Contact information
  • Disclaimer
  • Privacy Policy

© ImmuPharma PLC 2005-2025 | All rights reserved